Long-term outcomes for patients with limited-stage follicular lymphoma: update of a population-based study-Reference-Cited by-同舟云学术

Long-term outcomes for patients with limited-stage follicular lymphoma: update of a population-based study

Published:2020-08-20 Issue:8 Volume:136 Page:1006-1010
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Lo Andrea C.¹²^ORCID,Campbell Belinda A.³^ORCID,Pickles Tom¹²^ORCID,Aquino-Parsons Christina¹²,Sehn Laurie H.⁴⁵⁶,Connors Joseph M.⁴⁵⁶,Savage Kerry J.⁴⁵⁶^ORCID

Affiliation:

1. Department of Radiation Oncology, British Columbia Cancer, Vancouver, BC, Canada;

2. Department of Surgery, University of British Columbia, Vancouver, BC, Canada;

3. Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;

4. Department of Medical Oncology, British Columbia Cancer, Vancouver, BC, Canada;

5. Department of Medicine, University of British Columbia, Vancouver, BC, Canada; and

6. BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada

Abstract

With a median follow-up of 16.6 years, Lo and colleagues report excellent long-term outcomes with primary radiotherapy for limited-stage follicular lymphoma in this month’s CME article.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/136/8/1006/1755374/bloodbld2019004588.pdf

Reference18 articles.

1. Randomized trial of systemic therapy after involved-field radiotherapy in patients with early-stage follicular lymphoma: TROG 99.03;MacManus;J Clin Oncol,2018

2. Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG [published correction appears in Blood. 2019;134(3):331];Brady;Blood,2019

3. Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance;Tobin;Blood Adv,2019

4. Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy;Campbell;Cancer,2010

5. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin’s lymphoma: a question of field size;Campbell;J Clin Oncol,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study;Leukemia & Lymphoma;2024-09-10

2. Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance;Internal Medicine Journal;2024-08

3. Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma;The Lancet Haematology;2024-07

4. Impact of age on long-term relative survival benefit of radiotherapy for early-stage grade I–II follicular lymphoma from the SEER database (2000–2015);Leukemia & Lymphoma;2023-11-21

5. Mosunetuzumab and the emerging role of T-cell-engaging therapy in follicular lymphoma;Future Oncology;2023-10